Rights and permissions
About this article
Cite this article
Indirect costs account for majority of migraine cost burden in Spain. Pharmacoecon. Outcomes News 458, 9 (2004). https://doi.org/10.2165/00151234-200404580-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404580-00020